Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1943 Neuroendocrine Tumors Committee of Reference Hospital: Evaluation of Health Care and Research Indicators

Introduction: Neuroendocrine tumors (NETs) require a multidisciplinary approach in expert centers which optimize results improving care and survival.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jimenez-Fonseca P, Vieitez J, Valdés N, Lauret M, Calvo-Temprano D,

Keywords: committee, indicator, multidisciplinary, resource,

#1133 Prognosis of Stage IV Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) According to the WHO Classification and the Primary Tumor Location

Introduction: WHO classification of GEP-NET is used to predict prognosis, yet survival within each grade shows wide variation. We hypothesized that primary tumor location may be partially responsible of this variability.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Carmona-Bayonas A

Authors: Carmona-Bayonas A, Jiménez-Fonseca P, Vieitez J, Menendez Prieto M, Soli M,

Keywords: GEP-NET, WHO classification, grade, survival,

#1116 Streptozotocin Based Chemotherapy in Advanced G2 Pancreatic Neuroendocrine Tumors (PNET): Efficacy According to KI67 Index

Introduction: Streptozotocin (STZ) with fluorouracil (FU) or doxorubicin (DOX) is approved in well differentiated advanced pancreatic neuroendocrine tumors (PNET).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Jimenez-Fonseca P

Authors: Jiménez-Fonseca P, Carmona-Bayonas A, Solís M, Vieitez J, Sanchez M,

Keywords: chemotherapy, streptozotocin, fluorouracil, PNET, Ki67,

#257 Doxorubicin, Etoposide and Cisplatin as first-line Treatment in Advanced Adrenocortical Carcinoma

Introduction: Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis in advanced setting due to its low chemosensibility. Mitotane and cisplatin-based regimens are the most frequently used treatments.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca F, Vieitez J, Crespo G, Frunza M, Izquierdo M,

Keywords: adrenocortical carcinoma, chemotherapy, cisplatin-regimen, Doxorrubicin, Etoposide, Mitotane,

#253 Description and Treatment of GEP NETs in a Spanish Hospital During 10 Years

Introduction: In our area the GEP NET incidence is similar to that of gastric and exocrine pancreatic cancers consequently being important to know their characteristics and the most convenient therapeutic approach.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vieitez J, Galvan J, Crespo G, Frunza M,

Keywords: gastroenteropancreatic neuroendocrine tumors, histology, chemotherapy, streptozocin-based regimen,